Global Health Economics and Outcomes Research
Gilead Sciences, Inc.
Disclosure(s): Gilead Sciences, Inc.: Stocks/Bonds (Public Company)
Uche Mordi, PharmD, MS, currently serves as Associate Director of Global Health Economics and Outcomes Research at Gilead. In this capacity, she leads value-based evidence generation in HIV treatment.
She earned her Doctor of Pharmacy from the University of California, San Francisco, and a Master of Science in Pharmaceutical Outcomes & Policy (with a concentration in Applied Pharmacoeconomics) from the University of Florida. Her previous experience includes field-based HEOR positions at Bristol Myers Squibb and Eli Lilly, as well as HEOR consulting at Curta Health. In addition to her knowledge within infectious diseases, Dr. Mordi has extensive experience across therapeutic areas, including cardiovascular, immunology, neurosciences, and oncology.